Northwire Canada EditionFriday, July 24, 2026
Sign inSubscribe
Northwire
⌕
AVX 0.005 −nan% AII 19.91 −1.0% GWM 0.480 +0.0% GEN 0.065 +0.0% NIO 0.135 −3.6% III 7.22 −2.8% NCAU 0.295 −3.3% NEV 0.040 +0.0% ITR 3.00 −1.6% ALDE 2.79 −0.7% TECK 84.18 +4.4% FVI 11.83 −2.2% SUM 1.31 −1.5% RSMX 0.115 +4.5% STW 0.105 +5.0% PAT 0.250 +0.0% AVX 0.005 −nan% AII 19.91 −1.0% GWM 0.480 +0.0% GEN 0.065 +0.0% NIO 0.135 −3.6% III 7.22 −2.8% NCAU 0.295 −3.3% NEV 0.040 +0.0% ITR 3.00 −1.6% ALDE 2.79 −0.7% TECK 84.18 +4.4% FVI 11.83 −2.2% SUM 1.31 −1.5% RSMX 0.115 +4.5% STW 0.105 +5.0% PAT 0.250 +0.0%
M&A / Property

Sweet Earth clarifies info; Vesalius RTO closing delayed

By The Northwire Desk — AI Analysis Feb 06, 2026 · 16:33 SE · None Sweet Earth Holdings Corp
SE · Price

Executive Summary

  • Sweet Earth Holdings Corp. confirms that the Vesalius reverse‑takeover (RTO) is now expected to close in Q2 2026, delayed from earlier guidance.
  • The delay is attributed to board and management changes at Vesalius; three senior individuals will no longer hold positions post‑closing.
  • Clarifies current appointments of Shannon Anderson (director) and Chris Cooper (CFO) as administrative, non‑related‑party roles supporting the RTO.

Key Details

  • The British Columbia Securities Commission review prompted Sweet Earth to issue a clarification/retraction of its June 18 2025 announcement.
  • Vesalius Longevity Labs (Canada) Inc., via Vesalius USA Inc., continues commercial manufacturing of peptide products in a CGMP‑certified Section 503A compounding pharmacy, complying with FDA regulations.
  • Expected RTO closing moved to Q2 2026; original target date not specified but earlier than this.
  • Board/Management changes at Vesalius: Kevin Rabbitt, Mark Patricof, and Richard Serbin will no longer hold positions with Vesalius or the combined issuer after the transaction.
  • Current appointed individuals:
  • Shannon Anderson – Director of Sweet Earth (appointed Dec 20 2024), Vesalius (appointed Jan 27 2025) and SPV (appointed Mar 12 2025).
  • Chris Cooper – CFO of Vesilius (appointed Nov 28 2025) and Sweet Earth (appointed May 15 2020).
  • Both Anderson and Cooper are serving in an administrative capacity to assist the amalgamating parties; they are not considered related parties under IAS 24.
  • No change to the commercial operations of Vesalius USA Inc.; peptide product line remains active for licensed health‑care providers.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from Sweet Earth Holdings Corp

Mar 11, 2026 · 18:09

Sweet Earth amends merger agreement with Vesalius

M&A / Property